Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNuScience Medical Biologics, LLC

About this trial

This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Chronic Pressure Ulcers

Eligibility criteria

Qualifiers

Male or Female, 18 years of age or older

Subject has a medical diagnosis of Pressure Injury/Ulcer located on the pelvis or lower extremity

Subject has a Pressure Injury/Ulcer Stage 2 or 3 without infection

Index ulcer is a minimum of 1cm2 and a maximum of 30cm2 at first treatment visit

Disqualifiers

Subject has a known life expectancy of <1 year

Subject is unable to comply with protocol treatment

Subject has major uncontrolled medical disorders in the opinion of the investigator, such as serious cardiovascular, renal, liver, pulmonary, autoimmune, palliative care, or inherited blood disorders that may affect wound healing in the opinion of the investigator

Subject actively being treated for malignant disease or history of malignancy or radiation therapy at the site of wound

Trial design

Treatments tested in this trial

  • NeoThelium FT (HCT/P 361)

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators